Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation

T Beppu, K Sugimoto, K Shiraki… - International …, 2010 - spandidos-publications.com
The aim of this study was to elucidate the importance of three tumor markers, α-fetoprotein
(AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-γ-carboxy …

Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma.

C Ogawa, M Kudo, Y Minami, H Chung… - Hepato …, 2008 - europepmc.org
Results Multivariate analysis revealed that of the three tumor makers only AFP-L3 showed
significant differences in the survival and disease-free rates. Conclusions AFP-L3 is the most …

Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

C Dohi, K Nouso, K Miyahara, Y Morimoto… - Hepatology …, 2016 - Wiley Online Library
Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma

M Canale, P Ulivi, FG Foschi, E Scarpi… - Critical Reviews in …, 2018 - Elsevier
Radiofrequency ablation (RFA) is an effective local treatment for curative intent in patients
with cirrhosis of the liver and hepatocellular carcinoma (HCC) with diameter< 3 cm. Several …

[HTML][HTML] α-Fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) in prognosis of hepatocellular carcinoma after radiofrequency

A Shawky Elsawabi, K Abdel wahab, W Ibrahim… - Egyptian Liver …, 2019 - Springer
Background Numerous hepatocellular carcinoma (HCC) biomarkers have been assessed in
the diagnosis and prognosis of HCC. The aim of this study was to assess the value of α …

Evaluation of alpha‐fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation

S Siripongsakun, SH Wei, S Lin, J Chen… - Journal of …, 2014 - Wiley Online Library
Abstract Background and Aim The performance of alpha‐fetoprotein (AFP) in the detection
of hepatocellular carcinoma (HCC) recurrence after radiofrequency ablation was analyzed …

Pre-treatment double-or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma

H Nitta, S Nakagawa, T Kaida, K Arima, T Higashi… - Surgery today, 2017 - Springer
Purposes We evaluated the therapeutic effect of radiofrequency ablation (RFA) on
hepatocellular carcinoma (HCC) according to the number of positive tumor markers …

Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase–platelet …

WY Kao, YY Chiou, HH Hung, YH Chou… - European journal of …, 2011 - journals.lww.com
Objective Percutaneous radiofrequency ablation (RFA) is one of the first-line curative
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …

[HTML][HTML] Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the …

SW Shin, WK Jeong, S Lim, Y Kim… - Clinical and Molecular …, 2015 - ncbi.nlm.nih.gov
Methods This retrospective analysis included 65 patients (44 males, 21 females) who
underwent RFA of HCC. Hematologic and biochemical markers were assessed at the pre …

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

WY Kao, YY Chiou, HH Hung, CW Su, YH Chou… - Clinical radiology, 2012 - Elsevier
AIMS: To evaluate the clinical inference of serum alpha-fetoprotein (AFP) response in
hepatocellular carcinoma (HCC) patients undergoing percutaneous radiofrequency ablation …